Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
· ·
$12.10
▲ $0.01 (+0.1%)
Market data updated: 09/19 06:47 AM
Fundamentals updated: 09/18/2026
News analyzed: 09/19/2026
Market Cap
$38.31M
Day Range
$12.05 - $12.10
52-Week Range
$6.75 - $130.37
Beta
—
Next Earnings
16.11.2026
Support
$11.11
Resistance
$13.50
+6.4% (1Y)
Strengths: 2/18 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
MACD
MACD histogram is positive — rising momentum
Technical
Biggest negative driver
Liquidity risk
Current ratio: 0.00
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
39
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
44
Quality
No data available
Value
50
Momentum
29
Risk
34
Sentiment
38
Fundamental
41
Institutional
67
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Aimei Health Technology Co., Ltd. has centered exclusively on its abrupt termination of a merger agreement with United Hydrogen Group Inc., announced on July 8, 2026. The move led to a sharp decline in the company’s share price, making it a top decliner in premarket and midday trading on July 9, 2026. No other significant developments or details were reported.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Aimei Health Technology Co., Ltd - Ordinary Share. News trend score: 38. Reason: 2 of the last 5 articles are negative, versus 0 positive.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
10
🎯 Conviction (vs. Emotion)
50
Psychology
100
Fundamentals
41
Technical
29
Valuation
50
A significant decline over time, but on unusually low trading volume — holders unwilling to accept the loss.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price (3M)
-65%
Market Narrative
40
Fundamental Reality
50
Narrative Gap
-10
🧠 StockIQ Psychologist
The stock’s dominant **Loss Aversion** state reflects a deep drawdown (-69.8% over three months), where investors prioritize cutting losses over chasing gains. Elevated volume (2.17x average) suggests defensive trading, while FOMO and panic signals are muted by weak momentum and sentiment. The narrative gap (-10) hints at a disconnect between market reality (strong loss aversion) and potential narratives of recovery. The key question: Will volume sustain as a defensive hedge, or will it fade if sentiment improves?
Updated: 09/08/2026, 11:30 PM
What could change this?
👥 What the crowd believes
"Aimei Health Terminates Merger Deal With United Hydrogen Group; Shares Drop Pre-Bell"
📈 4D Investor Psychology
Signal classification confidence: Medium (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Charles Mackay — 100/100
🔴 Weakest match
Walter Bagehot — 0/100
🗣️ Why do they disagree?
This stock sparks a sharp divide between methodologies that prioritize cyclical positioning and those that flag structural risks or data gaps. The highest-scoring approaches—Charles Mackay’s crowd psychology, Howard Marks’ market-cycle analysis, and Samuel Armstrong Nelson’s oversold assessment—all suggest the stock sits in a favorable phase of the cycle, with minimal signs of mania or overextension. Meanwhile, disciplined traders like Jack Schwager and Howard Marks (separately) see a balanced reward-to-risk profile, reinforcing a cautious but constructive view. However, the sharp contrast emerges with methodologies that demand deeper fundamental or liquidity scrutiny: Benjamin Graham, Walter Bagehot, and Morgan Housel all dismiss it outright due to insufficient data or volatility concerns, while Philip Fisher and Peter Lynch lack conviction due to missing growth or fundamentals. Even Gerald Loeb and Jesse Livermore warn of hidden risks—whether in capital preservation or trend alignment—highlighting how the stock’s ambiguity leaves it vulnerable to conflicting interpretations.
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 100
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 100
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 91
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 70
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 53
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 50
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Peter Lynch
One Up on Wall Street (1989)
🟡 50
Not enough growth data for a real Lynch read
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Jack Schwager
Market Wizards (1989)
🔴 30
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 26
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🔴 23
Weak case — Malkiel/Bogle would say a low-cost index is the simpler bet
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🔴 22
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🔴 15
Not enough dividend/growth data for a real Smith read
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 1
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 0
Not enough balance-sheet/valuation data for a real Graham read
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 15%
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🔴 0
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 0
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 20%
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (2 bullish · 8 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
A trading range after a decline, but still without clear (volume-based) confirmation of an accumulation phase.
Low confidence
$11.11
Range Bottom
$13.50
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
—
EBITDA Margin
—
ROE
-26.1%
ROA
8.8%
ROIC
—
EPS
—
Cash
—
Total Debt
—
Current Ratio
0.00
Debt/Equity
—
אין נתונים היסטוריים זמינים.
אין נתונים היסטוריים זמינים.
אין נתונים היסטוריים זמינים.
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
—
Tangible Book Value per Share (Tangible NAV)
—
Not enough data to compute signals.
Sentiment based on basic keywords (not AI) — 0 positive, 3 neutral, 2 negative out of the last 5 articles.
MT Newswires · 9.7.2026
MT Newswires · 9.7.2026
MT Newswires · 9.7.2026
MT Newswires · 9.7.2026
GlobeNewswire · 8.7.2026
Aimei Health Technology Co., Ltd - Ordinary Share (AFJK) currently has a StockIQ AI score of 39/100, rated "Weak" (a partial score — based on only 6 of 7 categories, some data is currently unavailable). The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
AFJK currently scores 39/100 (Weak) across the categories we measure (a partial score — based on only 6 of 7 categories, some data is currently unavailable). StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
AFJK's technical score is 29/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: MACD histogram is positive — rising momentum; ROC 12 days: 0.3%.
Based on the real signals StockIQ computed: Current ratio: 0.00; Calmar: 0.08 (3y annualized return 6.7% / max drawdown 86.8%); Return on equity (ROE): -26.1% (negative).
StockIQ has no recorded dividend payment history for AFJK.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 2 purchases and 1 sales out of the last 3 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| MIZUHO SECURITIES USA LLC | Open Market Sale | 11.2.2025 | 150,000 | -150,000 | $10.86 |
| Aimei Investment Ltd | Open Market Purchase | 1.12.2023 | 332,000 | +332,000 | $10.00 |
| Aimei Investment Ltd | Open Market Purchase | 1.12.2023 | 332,000 | +332,000 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
2,559 shares short as of 2026-08-31 · vs. 2,344 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
41.4% of trading volume this week was short selling, vs. 41.4% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology